Improving Quality of Life in Men and Women With Overweight or Obesity
Randomized, Controlled Trial of a Weight Loss Intervention in Improving Quality of Life in Men and Women With Overweight or Obesity
1 other identifier
interventional
370
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of the Noom Healthy Weight Program, a digital behavior change weight loss intervention, on quality of life as measured both by self-report and objective measures, compared to a waitlist control condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Apr 2021
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2021
CompletedStudy Start
First participant enrolled
April 15, 2021
CompletedFirst Posted
Study publicly available on registry
May 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2022
CompletedNovember 18, 2023
November 1, 2023
10 months
April 6, 2021
November 16, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Weight
Self Reported
4 months
In app engagement measures
Self reported and automatically recorded
4 months
Stress
Measured via heart rate variability; Data will be collected with a wearable tracking device (Oura Ring). Heart rate variability (HRV) measures the specific changes in time (or variability) between successive heart beats. The time between beats is measured in milliseconds (ms) and is called an "R-R interval" or "inter-beat interval (IBI).
4 months
Secondary Outcomes (8)
Self Reported Perceived Stress
4 months
Sleep Quality
4 months
Sleep Impact
4 months
Sleep Score
4 months
Appetite and food craving
4 months
- +3 more secondary outcomes
Other Outcomes (1)
COVID status
4 months
Study Arms (2)
Wait List
NO INTERVENTIONNoom Healthy Weight
EXPERIMENTALInterventions
Behavioral: Noom Healthy Weight; mobile behavior change program for weight loss with 1:1 coaching The intervention consists of a curriculum, provided through daily articles that users are encouraged to read; logging features for weight, meals, and physical activity; in-app groups; and a virtual coach, who will communicate with participants via in-app messaging. During the first week of the study, participants will be introduced to the program, the Noom app, and their coach. Coaches will use a secure dashboard to monitor patient progress, which is used to increase engagement and motivation. Participants are encouraged to log their weight and physical activity on a weekly basis, and meals daily.
Eligibility Criteria
You may qualify if:
- Able to understand and provide informed consent
- years old
- Self-report of good health (physical and mental)
- Not diagnosed with diabetes
- Overweight or obesity (BMI ≥ 25)
- Able to meet our criteria of adherence to the program (at least 1 engagement per week on one of the following: logged exercise, logged meals, steps, weigh-ins, coach messages, read articles, and days with at least one weigh-in.)
- For females
- Not within the 6 months postpartum time frame
- Not planning to become pregnant in the next 5 months.
You may not qualify if:
- Inability or unwillingness of a participant to give written informed consent
- Currently taking medication which affects sleep or heart rate (e.g., (i) central nervous system stimulants, (ii) respiratory medications, (iii) antihistamines, (iv) central acting hormones (e.g. corticosteroids, thyroid), (v) high-dose anticholinergics, (vi) and cannot be using the maximum recommended dose for antihypertensive medications or use of multiple antihypertensive medications)
- Current diagnosed mental health condition (except mild anxious or depressive symptoms)
- Current diagnosed sleep disorder or condition not related to obesity (e.g., narcolepsy)
- Currently pregnant or ≤ 6 months postpartum
- Currently participating in shift work and/or have travelled between time zones in the last month
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the quality of the data; E.g., evidence of an eating disorder, major chronic condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Noom Inc.lead
Study Sites (1)
Noom
New York, New York, 10001, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2021
First Posted
May 4, 2021
Study Start
April 15, 2021
Primary Completion
February 15, 2022
Study Completion
February 15, 2022
Last Updated
November 18, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share